Previous COVID-19 or MIS-C does not protect kids from omicron, study finds

Credit: Pixabay/CC0 Public Domain

Research drawing on the national Overcoming COVID-19 study, led by Boston Children's Hospital, and the hospital's own Taking On COVID-19 Together Group provides evidence that children who previously had COVID-19 (or the inflammatory condition MIS-C) are not protected against the newer omicron variant.

Vaccination, however, does afford protection, the study found. The findings, published in Nature Communications on May 27, parallel similar findings in adults.

"I hear parents say, 'Oh, my kid had COVID last year,'" says Adrienne Randolph, MD, MSc, of Boston Children's Hospital, who launched Overcoming COVID-19 in 2020. Randolph was senior author on the current paper with Surender Khurana, Ph.D., of the Food and Drug Administration's Division of Viral Products, Center for Biologics Evaluation and Research. "But we found that antibodies produced by prior infections in children don't neutralize , meaning that remain susceptible to omicron."

The researchers obtained from 62 children and adolescents hospitalized with severe COVID-19, 65 children and adolescents hospitalized with MIS-C, and 50 outpatients who had recovered from mild COVID-19. All the samples were taken during 2020 and early 2021, before the emergence of the omicron variant.

In the laboratory, they exposed the samples to a pseudovirus (derived from SARS-CoV-2, but stripped of its virulence), and measured how well antibodies in the samples were able to neutralize five different SARS-CoV-2 variants of concern: alpha, beta, gamma, delta, and omicron.

Overall, children and adolescents showed some loss of antibody cross-neutralization against all five variants, but the loss was most pronounced for omicron.

"Omicron is very different from previous variants, with many mutations on the spike protein, and this work confirms that it is able to evade the antibody response," says Randolph. "Unvaccinated children remain susceptible."

In contrast, children who had received two doses of COVID-19 vaccine showed higher neutralizing against the five variants, including omicron.

Randolph hopes these data will encourage parents to have their children and teens vaccinated.

Explore further

COVID vaccination of children age 5-11 cut omicron hospitalizations by 68%

More information: Juanjie Tang et al, Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C, Nature Communications (2022). DOI: 10.1038/s41467-022-30649-1
Journal information: Nature Communications

Citation: Previous COVID-19 or MIS-C does not protect kids from omicron, study finds (2022, May 27) retrieved 4 July 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors